ABBOTT LABORATORIES - COM (ABT)

Q3 2022 13F Holders as of 9/30/2022

Type / Class
Equity / COM
Number of holders
2577
Total shares
1.29B
Shares change
+1.78M
Total reported value, excl. options
$125B
Value change
+$155M
Put/Call ratio
0.88
Number of buys
1167
Number of sells
-1088
Price
$96.76

Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q3 2022

2,629 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q3 2022.
ABBOTT LABORATORIES - COM (ABT) has 2,577 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.29B shares .
Largest 10 shareholders include VANGUARD GROUP INC (155M shares), BlackRock Inc. (133M shares), Capital Research Global Investors (78.8M shares), STATE STREET CORP (74.1M shares), Capital International Investors (52.2M shares), MORGAN STANLEY (34.1M shares), GEODE CAPITAL MANAGEMENT, LLC (30.1M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (24.5M shares), NORTHERN TRUST CORP (24.1M shares), and BANK OF AMERICA CORP /DE/ (22M shares).
This table shows the top 2577 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.